Oura, the maker of smart health-tracking rings, has secured $200 million in Series D funding, pushing its valuation to $5.2 billion. The funding, led by Fidelity Management and glucose-monitoring giant Dexcom, will fuel Oura’s expansion into AI-driven innovations, product development, and potential acquisitions. Building on its recent partnership with Dexcom, Oura aims to integrate blood sugar monitoring into its devices, enhancing health insights for users. With 2.5 million rings sold and a doubling of revenue in 2024, Oura continues to lead the wearables market while scaling its reach through major retailers and partnerships with military research programs. What groundbreaking features could this AI-powered health ring bring next?
Oura closes $200M round, bringing its valuation to $5.2B (TechCrunch)
0